Deep venous thrombosis associated with factor V Leiden, G20210A mutation, and protein S deficiency [3]

American Journal of Medicine

Volumn 114, Issue 5, 2003, Pages 421-422

  Monsuez, Jean Jacques ^a   Bouali, Houria ^a   Serve, Emilie ^a   Boissonnas, Alain ^a   Alhenc Gelas, Martine ^b  

^a HÔPITAL PAUL BROUSSE   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; LOW MOLECULAR WEIGHT HEPARIN; PROTEIN S; PROTHROMBIN; WARFARIN;

ADULT; ANTICOAGULANT THERAPY; BLOOD CLOTTING FACTOR DEFICIENCY; BLOOD GAS ANALYSIS; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DEEP VEIN THROMBOSIS; ECHOGRAPHY; ELECTROCARDIOGRAM; FEMALE; GENE MUTATION; GENERAL CONDITION IMPROVEMENT; HUMAN; INTERNAL JUGULAR VEIN; LABORATORY TEST; LETTER; NEUROLOGIC EXAMINATION; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTEIN S DEFICIENCY; SUBCLAVIAN VEIN; THORAX RADIOGRAPHY;

EID: 0037397915     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(03)00004-4     Document Type: Letter

References (8)

1. Marinella M.A., Kathula S.K., Markert R.J. Spectrum of upper-extremity deep venous thrombosis in a community teaching hospital. Heart Lung. 29:2000;113-117.
2. Seligsohn U., Lubetsky A. Genetic susceptibility to venous thrombosis. N Engl J Med. 344:2001;1222-1231.
3. Martinelli I., Cattaneo M., Panzeri D., Taioli E., Mannucci P.M. Risk factors for deep venous thrombosis of the upper extremities. Ann Intern Med. 126:1997;707-711.
4. Heron E., Lozinguez O., Alhenc-Gelas M., Emmerich J., Fiessinger J.N. Hypercoagulable states in primary upper-extremity deep vein thrombosis. Arch Intern Med. 160:2000;382-386.
5. Vaya A., Todoli J., Ricart J., et al. Upper extremity deep vein thrombosis in a young patient double heterozygous for factor V Leiden and prothrombin G20210A mutation. Clin Appl Thromb Hemost. 7:2001;72-74.
6. Sullivan V.V., Wolk S.W., Whitehouse W.M. Simultaneous bilateral upper extremity venous thrombosis in a factor V Leiden heterozygote. Vasc Surg. 35:2001;361-368.
7. De Stefano V., Martinelli I., Mannucci P.M., et al. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation. N Engl J Med. 341:1999;801-806.
8. Meyer G., Emmerich J., Helley D., et al. Factors V Leiden and II 20210A in patients with symptomatic pulmonary embolism and deep vein thrombosis. Am J Med. 110:2001;12-15.